TNF-α Enhances the Therapeutic Effects of MenSC-Derived Small Extracellular Vesicles on Inflammatory Bowel Disease through Macrophage Polarization by miR-24-3p

Human menstrual blood-derived mesenchymal stem cells (MenSCs) and their secreted small extracellular vesicles (EVs) had been proven to relieve inflammation, tissue damage, and fibrosis in various organs. The microenvironment induced by inflammatory cytokines can promote mesenchymal stem cells (MSCs) to secrete more substances (including EVs) that could regulate inflammation. Inflammatory bowel disease (IBD) is a chronic idiopathic intestinal inflammation, the etiology and mechanism of which are unclear. At present, the existing therapeutic methods are ineffective for many patients and have obvious side effects. Hence, we explored the role of tumor necrosis factor α- (TNF-α-) pretreated MenSC-derived small EV (MenSCs-sEVTNF-α) in a mouse model of dextran sulfate sodium- (DSS-) induced colitis, expecting to find better therapeutic alterations. In this research, the small EVs of MenSCs were obtained by ultracentrifugation. MicroRNAs of small EVs derived from MenSCs before and after TNF-α treatment were sequenced, and the differential microRNAs were analyzed by bioinformatics. The small EVs secreted by TNF-α-stimulating MenSCs were more effective in colonic mice than those secreted directly by MenSCs, as evidenced by the results of histopathology analysis of colonic tissue, immunohistochemistry for tight junction proteins, and enzyme-linked immunosorbent assay (ELISA) for cytokine expression profiles in vivo. The process of MenSCs-sEVTNF-α relieving colonic inflammation was accompanied by the polarization of M2 macrophages in the colon and miR-24-3p upregulation in small EVs. In vitro, both MenSC-derived sEV (MenSCs-sEV) and MenSCs-sEVTNF-α reduced the expression of proinflammatory cytokines, and MenSCs-sEVTNF-α can increase the portion of M2 macrophages. In conclusion, after TNF-α stimulation, the expression of miR-24-3p in small EVs derived from MenSCs was upregulated. MiR-24-3p was proved to target and downregulate interferon regulatory factor 1 (IRF1) expression in the murine colon and then promoted the polarization of M2 macrophages. The polarization of M2 macrophages in colonic tissues then reduced the damage caused by hyperinflammation.

[1]  E. Candi,et al.  The secretion profile of mesenchymal stem cells and potential applications in treating human diseases , 2022, Signal Transduction and Targeted Therapy.

[2]  D. Bokov,et al.  Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. , 2022, International immunopharmacology.

[3]  F. Sánchez-Margallo,et al.  IFN-Gamma and TNF-Alpha as a Priming Strategy to Enhance the Immunomodulatory Capacity of Secretomes from Menstrual Blood-Derived Stromal Cells , 2021, International journal of molecular sciences.

[4]  Jun Liu,et al.  Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases , 2021, Frontiers in Immunology.

[5]  Pingdong Jia,et al.  Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: A multiomics sequencing study with partial validation. , 2021, International immunopharmacology.

[6]  C. Xiang,et al.  Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine , 2021, Stem Cell Research & Therapy.

[7]  Xiaolan Zhang,et al.  A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6 , 2021, Stem cell research & therapy.

[8]  M. Neurath,et al.  Role of the IL23/IL17 Pathway in Crohn’s Disease , 2021, Frontiers in Immunology.

[9]  S. Hashemi,et al.  Adipose‐derived mesenchymal stem cell‐secreted exosome alleviates dextran sulfate sodium‐induced acute colitis by Treg cell induction and inflammatory cytokine reduction , 2021, Journal of cellular physiology.

[10]  R. Xu,et al.  Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial , 2021, Signal Transduction and Targeted Therapy.

[11]  T. Taketomi,et al.  Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss , 2020, Acta biomaterialia.

[12]  C. Xiang,et al.  Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases , 2020, World journal of stem cells.

[13]  C. Xiang,et al.  Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects , 2020, Stem Cell Research & Therapy.

[14]  T. Ye,et al.  AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization , 2020, Theranostics.

[15]  D. Xie,et al.  Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway , 2020, Stem Cell Research & Therapy.

[16]  Qiang Zhao,et al.  IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization , 2020, Theranostics.

[17]  Zhiwei Xu,et al.  HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice , 2020, Clinical and translational medicine.

[18]  Jiafeng Lin,et al.  Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR‐mediated autophagy flux pathway , 2020, Journal of cellular and molecular medicine.

[19]  Y. Zou,et al.  Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis , 2020, Stem Cell Research & Therapy.

[20]  L. Peyrin-Biroulet,et al.  Positioning therapies in ulcerative colitis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  A. Arsenijević,et al.  Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma , 2019, Stem cells international.

[22]  Xiaowen He,et al.  Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. , 2019, JCI insight.

[23]  Yue Zhou,et al.  The MSC-Derived Exosomal lncRNA H19 Promotes Wound Healing in Diabetic Foot Ulcers by Upregulating PTEN via MicroRNA-152-3p , 2019, Molecular therapy. Nucleic acids.

[24]  Jilong Shen,et al.  Toxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages , 2019, World journal of gastroenterology.

[25]  C. Xiang,et al.  Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases , 2019, Stem Cell Research & Therapy.

[26]  J. Cui,et al.  Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways , 2019, Cell.

[27]  J. Mehta,et al.  Sustained Delivery System for Stem Cell-Derived Exosomes , 2019, Front. Pharmacol..

[28]  J. S. Heo,et al.  Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes , 2019, Stem cells international.

[29]  P. He,et al.  Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis , 2019, Front. Immunol..

[30]  S. Vermeire,et al.  Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling , 2019, Gut.

[31]  Zhiwei Dong,et al.  MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing , 2019, Stem cells international.

[32]  G. Matteoli,et al.  Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD , 2019, Nature Reviews Gastroenterology & Hepatology.

[33]  C. Xiang,et al.  Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements , 2019, Stem Cell Research & Therapy.

[34]  H. Ji,et al.  YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis. , 2019, Cell reports.

[35]  S. Lim,et al.  MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. , 2019, Biomaterials.

[36]  Xuan Sun,et al.  Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization , 2019, Cardiovascular research.

[37]  C. Xiang,et al.  The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine , 2019, Stem Cell Research & Therapy.

[38]  A. Ivens,et al.  Dynamics of Colon Monocyte and Macrophage Activation During Colitis , 2018, Front. Immunol..

[39]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[40]  Yongmin Yan,et al.  Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. , 2018, ACS nano.

[41]  C. Shao,et al.  Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases , 2018, Nature Reviews Nephrology.

[42]  Y. Takakura,et al.  Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application. , 2018, Biological & pharmaceutical bulletin.

[43]  L. Öhman,et al.  Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies , 2018, Scandinavian journal of gastroenterology.

[44]  S. Lim,et al.  MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. , 2018, Biomaterials.

[45]  S. Neelamegham,et al.  The microRNA regulatory landscape of MSC-derived exosomes: a systems view , 2018, Scientific Reports.

[46]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[47]  A. Orekhov,et al.  The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. , 2018, Immunobiology.

[48]  M. Ericsson,et al.  Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.

[49]  C. Dörfer,et al.  IL-1/TNF-α Inflammatory and Anti-Inflammatory Synchronization Affects Gingival Stem/Progenitor Cells' Regenerative Attributes , 2017, Stem Cells International.

[50]  D. Prockop,et al.  Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus , 2017, Proceedings of the National Academy of Sciences.

[51]  M. Pittenger,et al.  Concise Review: MSC‐Derived Exosomes for Cell‐Free Therapy , 2017, Stem cells.

[52]  A. Gasbarrini,et al.  Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future , 2017, Expert review of clinical immunology.

[53]  R. Owens,et al.  Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease , 2017, Nature Medicine.

[54]  M. Chopp,et al.  MicroRNA-17–92 Cluster in Exosomes Enhance Neuroplasticity and Functional Recovery After Stroke in Rats , 2017, Stroke.

[55]  C. Xiang,et al.  Human Menstrual Blood‐Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators , 2016, Stem cells translational medicine.

[56]  C. Xiang,et al.  Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure , 2017, Stem Cell Research & Therapy.

[57]  J. Schaefer MicroRNAs: how many in inflammatory bowel disease? , 2016, Current opinion in gastroenterology.

[58]  P. Gros,et al.  The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation , 2016, The Journal of experimental medicine.

[59]  Suk-Kyun Yang Personalizing IBD Therapy: The Asian Perspective , 2016, Digestive Diseases.

[60]  G. Kaplan,et al.  The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.

[61]  S. Rutella,et al.  Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. , 2015, Gastroenterology.

[62]  Xiaoming Fan,et al.  The pathological role of microRNAs and inflammation in colon carcinogenesis. , 2015, Clinics and research in hepatology and gastroenterology.

[63]  T. Anchordoquy,et al.  Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[64]  M. Cottone,et al.  Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. , 2014, World journal of gastroenterology.

[65]  C. Xiang,et al.  Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice. , 2014, Stem cells and development.

[66]  Markus F. Neurath,et al.  Cytokines in inflammatory bowel disease , 2014, Nature Reviews Immunology.

[67]  T. Ritter,et al.  Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots? , 2013, Stem cells.

[68]  Dan Knights,et al.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.

[69]  S. O'Dea,et al.  IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. , 2013, Stem cells and development.

[70]  N. Kosaka,et al.  The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles , 2013, Proteomics.

[71]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[72]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[73]  Hao Wang,et al.  Endometrial regenerative cells: A novel stem cell population , 2007, Journal of Translational Medicine.

[74]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[75]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[76]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[77]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[78]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .